Trial Profile
A Retrospective Study of Palbociclib in Indian Patients with ER+, HER2 negative Metastatic Breast Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jun 2018
Price :
$35
*
At a glance
- Drugs Palbociclib (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology